Agilent Technologies, Inc. $A Shares Purchased by DAVENPORT & Co LLC

DAVENPORT & Co LLC lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 2,466.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 253,234 shares of the medical research company’s stock after purchasing an additional 243,365 shares during the quarter. DAVENPORT & Co LLC’s holdings in Agilent Technologies were worth $32,503,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital A Wealth Management LLC lifted its stake in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in Agilent Technologies during the 1st quarter worth $32,000. Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $33,000. State of Wyoming acquired a new stake in Agilent Technologies in the second quarter valued at $35,000. Finally, WFA of San Diego LLC bought a new position in shares of Agilent Technologies during the second quarter worth about $61,000.

Analyst Ratings Changes

A has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday. Morgan Stanley started coverage on Agilent Technologies in a research report on Tuesday, December 2nd. They set an “overweight” rating on the stock. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Barclays upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $161.77.

Agilent Technologies Stock Down 0.0%

Agilent Technologies stock opened at $138.32 on Thursday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The firm has a market cap of $39.21 billion, a price-to-earnings ratio of 30.27, a P/E/G ratio of 4.02 and a beta of 1.27. The firm has a fifty day moving average price of $145.44 and a two-hundred day moving average price of $130.55.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the prior year, the firm posted $1.46 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is 21.66%.

Insider Activity at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. This represents a 27.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 16,401 shares of company stock valued at $2,468,962 in the last 90 days.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.